Dyadic International, Inc.

US$0.34As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DYAIHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (14.48%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.08
PE TTM —
TSR TTM (69.93%)
Mkt cap US$12.38M
ROIC (203.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.425
25.13%
(75.88%)
Hold 3|12|12|1|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
12.02%
9.47%
3.41%
8.06%
Revenue$M
0.545
0.568
0.587
0.585
4.14%
10.80%
10.90%
13.51%
Peers (US$12.38M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.888
(1.469)
(1.205)
EBIT/Intx
1.331
0.125
0.112
Own earn%
222.01
(32.64)
(25.52)
Sh yield%
29.64
49.64
48.57
Owners
Insiders/Inst%
4.12
45.11
Short interest%
5.26
SBC / revenue%
3.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
18–24
$1 testx
—
Incr. ROIC%
12